Apellis Pharmaceuticals, Inc.

( )
APLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
MRKMerck & Co., Inc. 1.96%81.050.7%$1593.78m
JNJJohnson & Johnson -0.09%163.720.7%$1029.28m
PFEPfizer Inc. 1.76%42.830.9%$940.36m
ABBVAbbVie, Inc. 0.97%108.491.9%$680.09m
BMYBristol-Myers Squibb Co. 0.87%58.091.0%$658.95m
LLYEli Lilly & Co. 0.64%243.851.1%$610.94m
AZNAstraZeneca Plc 0.77%60.631.0%$366.84m
NVSNovartis AG 1.61%84.490.2%$176.86m
GSKGlaxoSmithKline Plc 0.74%39.460.2%$161.96m
RGENRepligen Corp. 2.13%268.256.8%$118.08m
AVIRAtea Pharmaceuticals, Inc. -4.20%13.240.3%$116.76m
VTRSViatris, Inc. 3.10%13.990.0%$92.80m
NVONovo Nordisk A/S -0.09%104.560.1%$91.61m
EDSAEdesa Biotech, Inc. -0.97%8.140.0%$73.37m
SNYSanofi 2.06%49.050.2%$64.75m

Company Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.